News on CardioVascular BioTherapeutics from BioPortfolio.com http://www.BioPortfolio.com Consolidated CardioVascular BioTherapeutics news from BioPortfolio.com Tue, 09 Feb 2010 23:03:27 GMT en Updates for Northwest Biotherapeutics (OTC:NWBO), Novavax (Nasdaq:NVAX), Osteologix (OTC:OLGX)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035375&HITNO=0&MSIZE=313&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CardioVascular%20BioTherapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035375&THISHREF=http://c.moreover.com/click/here.pl%3fz2536218102%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035375&HITNO=0&MSIZE=313&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CardioVascular%20BioTherapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035375&THISHREF=http://c.moreover.com/click/here.pl%3fz2536218102%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comLos Angeles Chronicle: Talecris Biotherapeutics Receives Orphan Drug Designation For Aerosolized Alpha1-Proteinase Inhibitor To Treathttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033014&HITNO=1&MSIZE=313&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CardioVascular%20BioTherapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033014&THISHREF=http://c.moreover.com/click/here.pl%3fz2534953678%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033014&HITNO=1&MSIZE=313&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CardioVascular%20BioTherapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033014&THISHREF=http://c.moreover.com/click/here.pl%3fz2534953678%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMediLexicon: Pfizer Q4 2009 Earnings Call Transcripthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035624&HITNO=2&MSIZE=313&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CardioVascular%20BioTherapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035624&THISHREF=http://c.moreover.com/click/here.pl%3fz2536301084%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035624&HITNO=2&MSIZE=313&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CardioVascular%20BioTherapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035624&THISHREF=http://c.moreover.com/click/here.pl%3fz2536301084%26amp%3bz%3d950242273&THEHOST=site+d.moreover.com123Jump: Pfizer Q4 2009 Earnings Call Transcripthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033600&HITNO=3&MSIZE=313&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CardioVascular%20BioTherapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033600&THISHREF=http://c.moreover.com/click/here.pl%3fz2535285697%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033600&HITNO=3&MSIZE=313&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CardioVascular%20BioTherapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033600&THISHREF=http://c.moreover.com/click/here.pl%3fz2535285697%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTicker: Northwest Biotherapeutics Inc. Appoints Market Media Connect as Communications Agency of Recordhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030761&HITNO=4&MSIZE=313&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CardioVascular%20BioTherapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030761&THISHREF=http://c.moreover.com/click/here.pl%3fz2533811145%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030761&HITNO=4&MSIZE=313&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CardioVascular%20BioTherapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030761&THISHREF=http://c.moreover.com/click/here.pl%3fz2533811145%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Northwest Biotherapeutics Inc. Appoints Market Media Connect as Communications Agency of Recordhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030103&HITNO=5&MSIZE=313&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CardioVascular%20BioTherapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030103&THISHREF=http://c.moreover.com/click/here.pl%3fz2533443418%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030103&HITNO=5&MSIZE=313&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CardioVascular%20BioTherapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030103&THISHREF=http://c.moreover.com/click/here.pl%3fz2533443418%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: Northwest Biotherapeutics Inc. Appoints Market Media Connect as Communications Agency of Recordhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029905&HITNO=6&MSIZE=313&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CardioVascular%20BioTherapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029905&THISHREF=http://c.moreover.com/click/here.pl%3fz2533329336%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029905&HITNO=6&MSIZE=313&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CardioVascular%20BioTherapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029905&THISHREF=http://c.moreover.com/click/here.pl%3fz2533329336%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Northwest Biotherapeutics Inc. Appoints Market Media Connect as Communications Agency of Recordhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028143&HITNO=7&MSIZE=313&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CardioVascular%20BioTherapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028143&THISHREF=http://c.moreover.com/click/here.pl%3fz2532595922%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028143&HITNO=7&MSIZE=313&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CardioVascular%20BioTherapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028143&THISHREF=http://c.moreover.com/click/here.pl%3fz2532595922%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: Northwest Biotherapeutics Inc. Appoints Market Media Connect as Communications Agency of Record / Biotech Company Taps Consultancy for Communications Expertisehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027913&HITNO=8&MSIZE=313&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CardioVascular%20BioTherapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027913&THISHREF=http://c.moreover.com/click/here.pl%3fz2532468704%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027913&HITNO=8&MSIZE=313&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CardioVascular%20BioTherapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027913&THISHREF=http://c.moreover.com/click/here.pl%3fz2532468704%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFinanzNachrichten.de: Market Media Connect retained as Northwest Biotherapeutics' communications agency of recordhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028017&HITNO=9&MSIZE=313&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CardioVascular%20BioTherapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028017&THISHREF=http://c.moreover.com/click/here.pl%3fz2532529605%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028017&HITNO=9&MSIZE=313&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CardioVascular%20BioTherapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028017&THISHREF=http://c.moreover.com/click/here.pl%3fz2532529605%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Medical News: Talecris Biotherapeutics Receives Orphan Drug Designation For Aerosolized Alpha1-Proteinase Inhibitor To Treat Alpha1-Antitrypsin Deficiencyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029518&HITNO=10&MSIZE=313&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CardioVascular%20BioTherapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029518&THISHREF=http://c.moreover.com/click/here.pl%3fz2533161744%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029518&HITNO=10&MSIZE=313&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CardioVascular%20BioTherapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029518&THISHREF=http://c.moreover.com/click/here.pl%3fz2533161744%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioFind: Talecris Biotherapeutics Receives Orphan Drug Designation For Aerosolized Alpha1-Proteinase Inhibitor To Treathttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028405&HITNO=11&MSIZE=313&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CardioVascular%20BioTherapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028405&THISHREF=http://c.moreover.com/click/here.pl%3fz2532704552%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028405&HITNO=11&MSIZE=313&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CardioVascular%20BioTherapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028405&THISHREF=http://c.moreover.com/click/here.pl%3fz2532704552%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: PREVIEW-Genzyme competition may get clearer at conferencehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031047&HITNO=12&MSIZE=313&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CardioVascular%20BioTherapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031047&THISHREF=http://c.moreover.com/click/here.pl%3fz2533958848%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031047&HITNO=12&MSIZE=313&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CardioVascular%20BioTherapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031047&THISHREF=http://c.moreover.com/click/here.pl%3fz2533958848%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comInteractive Investor: PREVIEW-Genzyme competition may get clearer at conferencehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030970&HITNO=13&MSIZE=313&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CardioVascular%20BioTherapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030970&THISHREF=http://c.moreover.com/click/here.pl%3fz2533920152%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030970&HITNO=13&MSIZE=313&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CardioVascular%20BioTherapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030970&THISHREF=http://c.moreover.com/click/here.pl%3fz2533920152%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFinanzNachrichten.de: PREVIEW-Genzyme competition may get clearer at conferencehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030937&HITNO=14&MSIZE=313&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CardioVascular%20BioTherapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030937&THISHREF=http://c.moreover.com/click/here.pl%3fz2533901639%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030937&HITNO=14&MSIZE=313&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=CardioVascular%20BioTherapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030937&THISHREF=http://c.moreover.com/click/here.pl%3fz2533901639%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comReuters: